Firebrick Pharma Limited (ASX:FRE)

Australia · Delayed Price · Currency is AUD

0.0580

0.00 (0.00%)

Mar 6, 2026, 2:43 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019
Pharmaceuticals	515.51K	2.75M	22.55K	1.08M	422.00K
Pharmaceuticals Growth	-81.26%	12096.48%	-97.92%	156.72%	-17.09%
Total	515.51K	2.75M	22.55K	1.08M	422.00K
Total Growth	-81.26%	12096.48%	-97.92%	156.72%	-17.09%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019
Asia	218.37K	9.64K	-	-	-
Asia Growth	2166.39%	-	-	-	-
North America	65.68K	4.89K	-	-	-
North America Growth	1244.06%	-	-	-	-
Europe and Others	9.37K	-	-	-	-
Australia	-	-	22.55K	1.08M	422.00K
Australia Growth	-	-	-97.92%	156.72%	-17.09%
Total	293.42K	14.52K	22.55K	1.08M	422.00K
Total Growth	1920.53%	-35.60%	-97.92%	156.72%	-17.09%

Source: S&P Global Market Intelligence.